
ChromaTan Inc.
Next Generation Platform for Gene Therapy and mRNA Manufacturing
- Stage $3M in TTM Revenue
- Industry Biotechnology
- Location Philadelphia, PA, USA
- Currency USD
- Founded January 2012
- Employees 16
- Incorporation Type C-corp
- Website chromatan.com
Company Summary
ChromaTan, a Blue Knight Company, has commercialized the first-ever, single-use, column-free and steady-state continuous chromatography platform called BioRMB that revolutionizes gene therapy and mRNA manufacturing. The company has several pilot units sold to major pharma companies
Studies with leading gene therapy companies have shown up to 20-fold improvements in productivity, using only 10% of the expensive resins used in columns.
Team
-
CEO
Oleg Shinkazh, founder and CEO of ChromaTan and the inventor of Continuous Countercurrent Tangential Chromatography (CCTC) now marketed as BioRMB. Oleg is a chemical and biotechnology engineer with 22 years of experience in the biotechnology industry, specializing in downstream processing and purification of biologics. Oleg has been with ChromaTan since October 2009, leading technical and business development of the company.
-
Thiago Millen, PhDAssociate Director of Process Development
Thiago is an experienced bioprocess scientist with a broad background in mAbs, viral vectors downstream processing and analytics. Thiago has 13+ years of working experience at fast-paced biotech start-ups as well as large biopharmaceutical companies, in the US and in Brazil, with cross-functional research and development teams. Thiago joined ChromaTan in 2023 and is leading the Process Development team at the company
-
Associate Director, Operations
Human Resources Management, Project Management, Bookkeeping, Inventory
-
Vice President of Sales and Business Development
Scott Zobbi is a sales and business development leader with over 30 years of experience. He has a diverse background, from commercial manufacturing and training to product management and business development. Most recently he was Director of Business Development and Strategy at Teknova. Previously, Mr. Zobbi was the head of the POROS custom resin business while at ThermoFisher, fostering the adoption of custom process chromatography solutions
-
David FogelPart Time CFO
David Fogel (CPA) is Managing Director of Swifton CFOs LLC, an outsourced CFO firm that provides emerging businesses with cost-effective and strategic financial leadership. David’s expertise lies in constructing a reliable financial framework to attract funding. David is Adjunct Instructor of Entrepreneurial Finance at Northeastern University.
Previous Investors
-
Ben Franklin of Central PA $500,000UnconfirmedLife Science Greenhouse of Central PA $600,000UnconfirmedSeries A - Lehigh Valley Angels $215,000Unconfirmed
-
Series A - Ben Franklin of Southeastern PA $250,000UnconfirmedSeries A and Notes - $350,000 Sorensen Family OfficeUnconfirmedFrank Li - $1,000,000Unconfirmed
-
Zoic Capital - $600,000Unconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.